Join Servier & Oncodesign at the AACR Congress : April 14-18, Chicago, USA

CTIBiotech advances cancer treatments with state-of-the-art 3D-Bioprinting
CTIBiotech advances cancer treatments with state-of-the-art 3D-Bioprinting
22/03/2018
ASCO Annual Meeting: June 1-5, Chicago, USA
Servier (Alain BRUNO) will be present at ASCO Annual Meeting: June 1-5, Chicago, USA
27/03/2018

Join Servier & Oncodesign at the AACR Congress : April 14-18, Chicago, USA

AACR Congress : April 14-18, Chicago, USA

Join Servier & Oncodesign at the AACR Congress : April 14-18, Chicago, USA - Driving Innovative Cancer Science to Patient Care

Oncodesign will be present with a booth plus an outstanding series of posters and a talk. Pop at our booth #1946 to explore our expertise in drug discovery and our wider panels of expertise in oncology!

Interested in Next Generation of Kinase Inhibitors, Integrated Drug Discovery partner or services using our technological platforms?
Please come & visit us at booth #1946 to define how we can work together in oncology to make your drug a success.

Incredible series of posters & talk showing our deep expertise in Oncology:

POSTERS

“Development of a high throughput in vitro screening platform to identify novel inducers of immunological cell death”
Time: April 15, 2018, 1:00 PM - 5:00 PM
I read the abstract

“Modulating T cell immunity in tumors by targeting PD-L1 and neoantigens using a live attenuated oral Salmonella platform”
Time: April 15, 2018, 1:00 PM - 5:00 PM
I read the abstract

“Morab-202, a folate receptor alpha-targeted antibody-drug conjugate, shows a highly potent activity against a panel of FRA-expressing tumors”
Time: April 16, 2018, 8:00 AM - 12:00 PM
I read the abstract

“Single mouse preclinical trial: A tool for translational research”
Time: April 16, 2018, 1:00 PM - 5:00 PM
I read the abstract

“Humanized mouse models for evaluation of cancer therapies”
Time: April 18, 2018, 8:00 AM - 12:00 PM
I read the abstract

SCIENTIFIC PRESENTATION

“Advantages in using orthotopic syngeneic tumor models to evaluate immune-based approaches for cancer treatment”
Time: April 17, 2018, 4:35 PM - 4:50 PM
I read the abstract

Meet Oncodesign         Meet Servier



Get connected!

IMODI is now present on the Twitter and LinkedIn networks.
Follow us on @IMODI_Cancer and www.linkedin.com/company/imodi-cancer


Share this